Where Tomorrow’s Discoveries Begin
ScienceToday.ai delivers accurate, engaging, and search-optimized science stories designed for curious readers, educators, and professionals.
Health & Medicine
The Promise and Perils of GLP-1 Agonists: Revolutionizing Obesity and Diabetes Treatment
GLP-1 agonists like semaglutide and tirzepatide are transforming the management of obesity and type 2 diabetes. This article examines their mechanisms, benefits, risks, and the profound implications for public health.
GLP-1 agonists
semaglutide
tirzepatide
👁 31 • Mar 23, 2026
Health & Medicine
Type 2 Diabetes: Understanding the Epidemic, Latest Research, and Paths to Prevention
## Introduction Type 2 diabetes has emerged as one of the most pressing public health challenges of the 21st century, affecting hundreds of millions of people worldwide. Once considered a disease of adulthood, it is now…
type 2 diabetes
diabetes prevention
insulin resistance
👁 33 • Mar 21, 2026
